Quantitative Analysis of Oligonucleotide by Ion Paring Reversed-Phase LC-MS.MS

Oligonucleotides (OGNs) have attracted massive attention as therapeutics due to their ability to regulate gene expression precisely and efficiently. OGN bioanalysis is critical to evaluate its efficacy and toxicity.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Comments

This field is for validation purposes and should be left unchanged.

Quantitative Analysis of Oligonucleotide by Ion Paring Reversed-Phase LC-MS.MS

Resources to Consider

Quantitative Assessment of mRNA Drug Biological Activity by...

Quantitative Analysis of Antibody Conjugate Payload by LC MS/MS...

Quantitative Whole-Body Autoradiography (QWBA) and Radiation...

Comparison of the Quantitative Measurement of Albumin in Human…

IN Vitro Assessment of the inhibition of Human Organic Anion...

Bioanalysis of antibody-drug conjugates (ADCs) by LC/MS: challenges...

Achieving sensitive and specific oligonucleotide quantification by...

Characterization of Interchain Cysteine Linked Antibody Drug...

Determination of Pregabalinin Human Plasma by Liquid...

Addressing the Increasing Needs of Data Integrity by Implementing the...

A Hybrid Trial Approach by Combining 13C8-Lableded & Radiolabeled...

Bioanalysis of Liposome Drugs by LC-MS/MS